Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 451

1.

[Erratum to: New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk. Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Klose G, Beil FU, Dieplinger H, von Eckardstein A, Föger B, Gouni-Berthold I, Heigl F, Koenig W, Kostner GM, Landmesser U, Laufs U, Leistikow F, März W, Merkel M, Müller-Wieland D, Noll G, Parhofer KG, Paulweber B, Riesen W, Schaefer JR, Steinhagen-Thiessen E, Steinmetz A, Toplak H, Wanner C, Windler E.

Internist (Berl). 2014 Sep;55(9):1112. doi: 10.1007/s00108-014-3576-9. German. No abstract available.

PMID:
25193037
[PubMed - in process]
2.

Total Nutrition Therapy Renal: A Clinical Nutrition Education Program for Nephrologists and other Renal Health Care Professionals.

Ikizler TA, Wanner C.

J Ren Nutr. 2014 Sep 1. pii: S1051-2276(14)00114-9. doi: 10.1053/j.jrn.2014.06.006. [Epub ahead of print] No abstract available.

PMID:
25190486
[PubMed - as supplied by publisher]
3.

Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosis.

van der Tol L, Svarstad E, Ortiz A, Tøndel C, Oliveira JP, Vogt L, Waldek S, Hughes DA, Lachmann RH, Terryn W, Hollak CE, Florquin S, van den Bergh Weerman MA, Wanner C, West ML, Biegstraaten M, Linthorst GE.

Mol Genet Metab. 2014 Aug 20. pii: S1096-7192(14)00261-3. doi: 10.1016/j.ymgme.2014.08.007. [Epub ahead of print]

PMID:
25187469
[PubMed - as supplied by publisher]
4.

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry.

Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Aresté N, Alonso de la Torre R, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma A, de Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD; ERA-EDTA Registry.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv15-iv25. doi: 10.1093/ndt/gfu017.

PMID:
25165182
[PubMed - in process]
5.

Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry.

Wühl E, van Stralen KJ, Wanner C, Ariceta G, Heaf JG, Bjerre AK, Palsson R, Duneau G, Hoitsma AJ, Ravani P, Schaefer F, Jager KJ.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv1-iv8. doi: 10.1093/ndt/gfu030.

PMID:
25165174
[PubMed - in process]
6.

Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients.

Kalousová M, Zima T, Krane V, März W, Wanner C, Tesař V, Drechsler C; German Diabetes and Dialysis Study Investigators.

Atherosclerosis. 2014 Jul 12;236(2):263-269. doi: 10.1016/j.atherosclerosis.2014.07.003. [Epub ahead of print]

PMID:
25108075
[PubMed - as supplied by publisher]
Free Article
7.

Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients.

Wanner C, März W, Varushchanka A, Apanasovich N, Dosta N, Yakubtsevich R, Locatelli F.

Clin Nephrol. 2014 Sep;82(3):163-72.

PMID:
25079861
[PubMed - in process]
8.

Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in fabry disease.

Krämer J, Niemann M, Störk S, Frantz S, Beer M, Ertl G, Wanner C, Weidemann F.

Am J Cardiol. 2014 Sep 15;114(6):895-900. doi: 10.1016/j.amjcard.2014.06.019. Epub 2014 Jul 2.

PMID:
25073565
[PubMed - in process]
Free Article
9.

Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry.

Noordzij M, Jager KJ, van der Veer SN, Kramar R, Collart F, Heaf JG, Stojceva-Taneva O, Leivestad T, Buturovic-Ponikvar J, Benítez Sánchez M, Moreso F, Prütz KG, Severn A, Wanner C, Vanholder R, Ravani P.

Nephrol Dial Transplant. 2014 Jul 24. pii: gfu253. [Epub ahead of print]

PMID:
25061126
[PubMed - as supplied by publisher]
10.

HDL Cholesterol, Apolipoproteins, and Cardiovascular Risk in Hemodialysis Patients.

Silbernagel G, Genser B, Drechsler C, Scharnagl H, Grammer TB, Stojakovic T, Krane V, Ritz E, Wanner C, März W.

J Am Soc Nephrol. 2014 Jul 10. pii: ASN.2013080816. [Epub ahead of print]

PMID:
25012163
[PubMed - as supplied by publisher]
11.

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).

Zinman B, Inzucchi SE, Lachin JM, Wanner C, Ferrari R, Fitchett D, Bluhmki E, Hantel S, Kempthorne-Rawson J, Newman J, Johansen OE, Woerle HJ, Broedl UC.

Cardiovasc Diabetol. 2014 Jun 19;13:102. doi: 10.1186/1475-2840-13-102.

PMID:
24943000
[PubMed - in process]
Free PMC Article
12.

[The diabetic patient with nephropathy].

Drechsler C, Schneider A, Schmidt KR, Wanner C.

MMW Fortschr Med. 2014 May 15;156(9):41-4; quiz 45. Review. German. No abstract available.

PMID:
24908888
[PubMed - indexed for MEDLINE]
13.

Taming the chronic kidney disease epidemic: a global view of surveillance efforts.

Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N; CDC-CKD Surveillance Team, Brück K, Wanner C, Stel VS; European CKD Burden Consortium, Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG; CKD.QLD group, O'Donoghue D, Roderick P, Matsuo S, Hishida A, Imai E, Iimuro S.

Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.

PMID:
24897034
[PubMed - in process]
14.

Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.

Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; on behalf of the ERA-EDTA Registry; EuroCYST Consortium; the WGIKD.

Kidney Int. 2014 May 14. doi: 10.1038/ki.2014.120. [Epub ahead of print]

PMID:
24827775
[PubMed - as supplied by publisher]
15.

Single nucleotide variants in the protein C pathway and mortality in dialysis patients.

Ocak G, Drechsler C, Vossen CY, Vos HL, Rosendaal FR, Reitsma PH, Hoffmann MM, März W, Ouwehand WH, Krediet RT, Boeschoten EW, Dekker FW, Wanner C, Verduijn M.

PLoS One. 2014 May 9;9(5):e97251. doi: 10.1371/journal.pone.0097251. eCollection 2014.

PMID:
24816905
[PubMed - in process]
Free PMC Article
16.

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.

Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So WY, Wanner C, Kasiske BL, Wheeler DC, de Zeeuw D, Mogensen CE.

Kidney Int. 2014 Apr 30. doi: 10.1038/ki.2014.128. [Epub ahead of print]

PMID:
24786708
[PubMed - as supplied by publisher]
17.

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Klose G, Beil FU, Dieplinger H, von Eckardstein A, Föger B, Gouni-Berthold I, Koenig W, Kostner GM, Landmesser U, Laufs U, Leistikow F, März W, Merkel M, Müller-Wieland D, Noll G, Parhofer KG, Paulweber B, Riesen W, Schaefer JR, Steinhagen-Thiessen E, Steinmetz A, Toplak H, Wanner C, Windler E.

Internist (Berl). 2014 May;55(5):601-6. doi: 10.1007/s00108-014-3492-z. German.

PMID:
24770979
[PubMed - in process]
18.

New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk.

Klose G, Beil FU, Dieplinger H, von Eckardstein A, Föger B, Gouni-Berthold I, Heigl F, Koenig W, Kostner GM, Landmesser U, Laufs U, Leistikow F, März W, Noll G, Parhofer KG, Paulweber B, Riesen WF, Schaefer JR, Steinhagen-Thiessen E, Steinmetz A, Toplak H, Wanner C, Windler E.

Wien Klin Wochenschr. 2014 Mar;126(5-6):169-75. doi: 10.1007/s00508-014-0513-9. Epub 2014 Mar 11.

PMID:
24615676
[PubMed - in process]
19.

Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch.

Weidemann F, Krämer J, Duning T, Lenders M, Canaan-Kühl S, Krebs A, Guerrero González H, Sommer C, Üçeyler N, Niemann M, Störk S, Schelleckes M, Reiermann S, Stypmann J, Brand SM, Wanner C, Brand E.

J Am Soc Nephrol. 2014 Apr;25(4):837-49. doi: 10.1681/ASN.2013060585. Epub 2014 Feb 20.

PMID:
24556354
[PubMed - indexed for MEDLINE]
20.

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.

Wanner C, Tonelli M; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members.

Kidney Int. 2014 Jun;85(6):1303-9. doi: 10.1038/ki.2014.31. Epub 2014 Feb 19.

PMID:
24552851
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk